Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure

被引:90
|
作者
Mujumdar, VS
Tyagi, SC
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc Renal Res, Jackson, MS 39216 USA
关键词
fibrosis; elastin; collagen; hypertension; hypertrophy; transforming growth factor-beta(1); decorin; matrix metalloproteinase-2; gelatinase A; tissue inhibitor of metalloproteinase-4; Wistar-Kyoto rats; spontaneously hypertensive rats; elastase;
D O I
10.1097/00004872-199917020-00011
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective Extracellular matrix, particularly type I fibrillar collagen, provides tensile strength that allows cardiac muscle to perform systolic and diastolic functions. Collagen is induced during the transition from compensatory hypertrophy to heart failure. We hypothesized that cardiac stiffness during decompensatory hypertrophy is partly due to a decreased elastin:collagen ratio. Materials and methods We prepared left ventricular tissue homogenates from spontaneously hypertensive rats (SHR) aged 30-36 weeks, which had compensatory hypertrophy with no heart failure, and from SHR aged 70-92 weeks, which had decompensatory hypertrophy with heart failure. Age- and sex-matched Wistar-Kyoto (WKY) rats were used as normotensive controls. In both SHR groups, increased levels of collagen were detected by immune-blot analysis using type I collagen antibody. Elastin and collagen were quantitated by measuring desmosine/isodesmosine and hydroxyproline spectrophometrically, respectively. To determine whether the decrease in elastin content was due to increased elastinolytic activity of matrix metalloproteinase-2, we performed gelatin and elastin zymography on left ventricular tissue homogenates from control rats, SHR with compensatory hypertrophy and SHR with heart failure. Results The elastin : collagen ratio was 0.242 +/- 0.008 in hearts from WKY rats. In SHR without heart failure, the ratio was decreased to 0.073 +/- 0.003 and in decompensatory hypertrophy with heart failure, the ratio decreased to 0.012 +/- 0.005. Matrix metalloproteinase-2 activity was increased significantly in SHR with heart failure compared with controls (P < 0.001). The level of tissue inhibitor of metalloproteinase-4 was increased in compensatory hypertrophy and markedly reduced in heart failure. Decorin was strongly reduced in decompensatory heart failure compared with control hearts. Conclusions Since collagen was induced in SHR with heart failure, decorin and elastin were decreased and the ratios of gelatinase A and elastase to tissue inhibitor of metalloproteinase-4 were increased, we conclude that heart failure is associated with adverse extracellular matrix remodeling. (C) Lippincott Williams & Wilkins.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 50 条
  • [21] HEART FAILURE AND VENTRICULAR HYPERTROPHY - ALTERED CARDIAC CONTRACTILITY AND COMPENSATORY MECHANISMS
    SPANN, JF
    AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (04): : 504 - &
  • [22] Compensatory mechanisms of coronary reserve regulation in heart failure
    Cobet, Waleriu
    Ciobanu, L.
    Panfile, E.
    Moraru, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 301 - 301
  • [23] Altered energy substrate utilization in the transition from hypertrophy to heart failure
    Burnham, KM
    Weinheimer, CJ
    McCune, SA
    Kelly, DP
    Bergmann, SR
    CIRCULATION, 1997, 96 (08) : 1414 - 1414
  • [24] Activated E-protein kinase C accelerates the transition from compensatory left ventricular hypertrophy to heart failure in hypertensive rats
    Inagaki, K
    Begley, R
    Mochly-Rosen, D
    CIRCULATION, 2004, 110 (17) : 598 - 598
  • [25] Cardiac calcineurin during transition from hypertrophy to heart failure in rats
    Hayashida, W
    Kihara, Y
    Yasaka, A
    Sasayama, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (01) : 347 - 351
  • [26] REGULATION OF THE STRUCTURAL REMODELING OF THE MYOCARDIUM - FROM HYPERTROPHY TO HEART-FAILURE
    BRILLA, CG
    MAISCH, B
    EUROPEAN HEART JOURNAL, 1994, 15 : 45 - 52
  • [27] Extracellular matrix remodelling in myocardial hypertrophy and failure: focus on osteopontin
    Francia P.
    Uccellini A.
    Frattari A.
    Modestino A.
    Ricotta A.
    Balla C.
    Scialla L.
    Volpe M.
    High Blood Pressure & Cardiovascular Prevention, 2009, 16 (4) : 195 - 199
  • [28] AGING, EXTRACELLULAR MATRIX AND HEART FAILURE: 2015
    Jugdutt, B. I.
    CARDIOLOGY, 2015, 131 : 199 - 199
  • [29] The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
    Frangogiannis, Nikolaos G.
    CIRCULATION RESEARCH, 2019, 125 (01) : 117 - 146
  • [30] Extracellular matrix fibrotic markers in heart failure
    Faiez Zannad
    Patrick Rossignol
    Wafae Iraqi
    Heart Failure Reviews, 2010, 15 : 319 - 329